{"id":"crs-207","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Fatigue"},{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Chills"},{"rate":"5-10%","effect":"Fever"},{"rate":"5-10%","effect":"Muscle pain"},{"rate":"5-10%","effect":"Joint pain"},{"rate":"5-10%","effect":"Rash"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This vaccine works by infecting cells with a weakened form of Listeria monocytogenes, which then expresses mesothelin on its surface. The immune system recognizes this as foreign and mounts a response against the mesothelin-expressing cells, which are often cancer cells.","oneSentence":"CRS-207 is a live, attenuated Listeria monocytogenes vaccine that stimulates an immune response against mesothelin.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:29:44.633Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Mesothelioma"}]},"trialDetails":[{"nctId":"NCT05014776","phase":"PHASE2","title":"Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2022-08-22","conditions":"Pancreatic Cancer","enrollment":17},{"nctId":"NCT03006302","phase":"PHASE2","title":"Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2018-01-31","conditions":"Metastatic Pancreatic Adenocarcinoma","enrollment":41},{"nctId":"NCT03190265","phase":"PHASE2","title":"Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2017-12-14","conditions":"Pancreatic Cancer","enrollment":61},{"nctId":"NCT02243371","phase":"PHASE2","title":"GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2015-01-02","conditions":"Previously Treated Metastatic Adenocarcinoma of the Pancreas","enrollment":93},{"nctId":"NCT01675765","phase":"PHASE1","title":"Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma","status":"COMPLETED","sponsor":"Aduro Biotech, Inc.","startDate":"2014-09-03","conditions":"Malignant Pleural Mesothelioma","enrollment":60},{"nctId":"NCT03175172","phase":"PHASE2","title":"Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM)","status":"TERMINATED","sponsor":"Aduro Biotech, Inc.","startDate":"2017-05-31","conditions":"Malignant Pleural Mesothelioma","enrollment":10},{"nctId":"NCT02575807","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer","status":"TERMINATED","sponsor":"Aduro Biotech, Inc.","startDate":"2016-03-08","conditions":"Platinum-resistant Ovarian Cancer, Platinum-resistant Fallopian Cancer, Platinum-resistant Peritoneal Cancer","enrollment":35},{"nctId":"NCT03122548","phase":"PHASE2","title":"Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers","status":"TERMINATED","sponsor":"Aduro Biotech, Inc.","startDate":"2017-08-14","conditions":"Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma","enrollment":5},{"nctId":"NCT02004262","phase":"PHASE2","title":"Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting","status":"COMPLETED","sponsor":"Aduro Biotech, Inc.","startDate":"2014-02-05","conditions":"2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer","enrollment":303},{"nctId":"NCT01417000","phase":"PHASE2","title":"Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer","status":"COMPLETED","sponsor":"Aduro Biotech, Inc.","startDate":"2011-09-21","conditions":"Metastatic Pancreatic Cancer","enrollment":93},{"nctId":"NCT00585845","phase":"PHASE1","title":"Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment","status":"TERMINATED","sponsor":"Anza Therapeutics, Inc.","startDate":"2007-12","conditions":"Malignant Epithelial Mesothelioma, Adenocarcinoma of the Pancreas, Carcinoma, Non-Small-Cell Lung","enrollment":17}],"_emaApprovals":[],"_faersSignals":[{"count":4,"reaction":"MALIGNANT NEOPLASM PROGRESSION"},{"count":3,"reaction":"DEHYDRATION"},{"count":3,"reaction":"PNEUMONIA"},{"count":3,"reaction":"SEPSIS"},{"count":2,"reaction":"ACUTE KIDNEY INJURY"},{"count":2,"reaction":"CHOLANGITIS"},{"count":2,"reaction":"DIARRHOEA"},{"count":2,"reaction":"RECTAL HAEMORRHAGE"},{"count":2,"reaction":"SYNCOPE"},{"count":1,"reaction":"ABDOMINAL PAIN"}],"_approvalHistory":[],"publicationCount":15,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Live, attenuated double-deleted Listeria monocytogenes (LADD)"],"phase":"phase_2","status":"active","brandName":"CRS-207","genericName":"CRS-207","companyName":"Aduro Biotech, Inc.","companyId":"aduro-biotech-inc","modality":"Biologic","firstApprovalDate":"","aiSummary":"CRS-207 is a live, attenuated Listeria monocytogenes vaccine that stimulates an immune response against mesothelin. Used for Mesothelioma.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":7,"withResults":7},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}